7 May 2021PatentsAlex Baldwin

US backs COVID IP waiver - Industry reacts

After months of open letters and petitions from various sources, the US government has decided to throw its support behind waiving IP rights for COVID-19 vaccines.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Patents

Biden backs TRIPS waiver for COVID-19 vaccines

6 May 2021 President Joe Biden has backed the waiving of IP rights for COVID-19 vaccines following mounting pressure from countries, charities and industry bodies.

Patents

LSPN Connect: will nationalism block access to a COVID-19 vaccine?

20 October 2020 As scientists around the globe race to find a vaccine for COVID-19, the big question for many is whether competition between nation-states will interfere with citizens’ access to these life-saving treatments.

‘We created law’: G1/24 and the creation of the ‘diamond standard’

Tech litigators join Hogan Lovells’ Paris practice from A&O Shearman

How in-house patent pros are ‘enablers of innovation’

Smart IP for startups: how to avoid the common traps

Defending the realm: How a key MoD supplier crafts its IP strategy

How IP firms can champion LGBTQ+ staff beyond Pride 2025

WATCH: Synergy in science—navigating the landscape of pharmaceutical collaborations

AI patent trends signal tomorrow’s technologies

US backs COVID IP waiver - Industry reacts

More on this story

Editor's picks

Editor's picks

More articles